Proliferative glomerulonephritis with monoclonal IgG deposits triggered by Filgrastim in a patient with multiple myeloma

J Nephrol. 2023 May;36(4):1209-1212. doi: 10.1007/s40620-022-01555-y. Epub 2023 Jan 18.

Authors

Juan M Villegas-Gamas¹, Sofía E Márquez-Macedo¹, Brenda Jiménez-Franco², Jorge I Fonseca-Correa¹, Juan M Mejía-Vilet³

Affiliations

¹ Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
² Department of Internal Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
³ Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. juan.mejiav@incmnsz.mx.

PMID: 36652170
DOI: 10.1007/s40620-022-01555-y

No abstract available

Keywords: Acute kidney injury; Filgrastim; G-CSF; Glomerulonephritis; PGNMID.

MeSH terms

Antibodies, Monoclonal
Filgrastim / adverse effects
Glomerulonephritis*
Glomerulonephritis, Membranoproliferative*
Humans
Immunoglobulin G
Multiple Myeloma* / drug therapy
Neoplasm Recurrence, Local

Substances

Filgrastim
Antibodies, Monoclonal
Immunoglobulin G